A study using Swedish patient data found anti-obesity drugs were linked with fewer hospitalizations related to alcohol use, ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden ...

New research has found that nearly 137 million adults—or more than half of all U.S. adults—are eligible for semaglutide ...

Scientific evidence is mounting that the new class of GLP-1 receptor agonist weight-loss drugs—such as Ozempic, seen here on a production line—seem to help diminish cravings for alcohol ...

As GLP-1 medications like Ozempic soar in popularity, our new documentary follows three people on their weight-loss journeys ...

The costly proposal from the US Department of Health and Human Services sets the stage for a potential showdown between the powerful pharmaceutical industry and Robert F. Kennedy Jr., an ...

The drugs include Novo Nordisk’s Wegovy and Ozempic as well as Eli Lilly’s Zepbound and Mounjaro. In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an ...

As GLP-1 drugs like Ozempic soar in popularity for weight loss, this film follows three people on their own GLP-1 journeys and explores how decades of diet culture and society’s relentless pursuit of ...

A new study ties Ozempic use in people with Type 2 diabetes to a lower Alzheimer's risk. Researchers gleaned from the study published last month: These drugs like Ozempic and Wegovy treat diabetes ...